Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 509.00
Bid: 506.00
Ask: 512.00
Change: 11.00 (2.20%)
Spread: 6.00 (1.186%)
Open: 503.00
High: 512.00
Low: 508.00
Prev. Close: 501.00
OCI Live PriceLast checked at -
Oakley Capital Investments is an Investment Trust

To achieve capital appreciation through investments in a diversified portfolio of private mid-market businesses primarily in Europe.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Interim Results and Webcast Presentation

25 Aug 2021 07:00

RNS Number : 6624J
Oakley Capital Investments Limited
25 August 2021
 

25 August 2021

Oakley Capital Investments Limited 

 

Notice of Interim Results and Webcast Presentation

 

Oakley Capital Investments Limited1a listed investment company that provides access to market leading private equity returns by investing in the funds managed by Oakley Capital2, will announce its interim results for the six months ended 30 June 2021 on Thursday 9 September 2021.

 

A live presentation of the results, delivered by Oakley Capital Partner Steven Tredget, will be broadcast online at 09.00 BST on the day.

 

To register your attendance at the event, please email oakley@greenbrookpr.com. Please note that only registered sell-side analysts will be able to ask questions during the event. 

 

A recording of the webcast presentation will also be available on the Oakley Capital Investments website shortly after the event.

- ends -

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook Communications Limited

+44 20 7952 2000

Alex Jones / Michael Russell

 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Chris Clarke / Darren Vickers / Owen Matthews

 

Notes:

 

LEI Number: 213800KW6MZUK12CQ815

 

About Oakley Capital Investments Limited ("OCI")

 

OCI is a Specialist Fund Segment ("SFS") traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

An introduction to OCI video is available at https://oakleycapitalinvestments.com/videos/

 

The Oakley Funds

 

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV and Oakley Capital Origin Fund are unlisted lower-mid to mid-market private equity funds with the aim of providing investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

 

The Investment Adviser

 

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

 

Important information

 

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

 

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOREANPLAEAFEFA
Date   Source Headline
20th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
30th May 20197:00 amRNSInspired welcomes Warburg Pincus as an Investor
13th May 201911:52 amRNSAcquisition of Videotel and Seagull
1st May 20197:00 amRNSAcquisition of stake in Rastreator and Acierto
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading update for the year ended 31 December 2018
3rd Jan 20197:00 amRNSCapital Commitment
14th Nov 20183:58 pmRNSDirector Dealing
8th Nov 20187:00 amRNSInvestment Activity Update
24th Oct 20181:30 pmRNSDirector Dealing
12th Oct 20183:07 pmRNSDirector Dealing
25th Sep 20187:00 amRNSAppointment of Non-Executive Director
11th Sep 20187:00 amRNSBoard Changes
6th Sep 20187:00 amRNSHalf-year Report
21st Aug 20187:00 amRNSOakley Capital to invest in cPanel
27th Jul 20184:40 pmRNSHolding(s) in Company
26th Jul 20187:00 amRNSTrading Update
6th Jul 20187:00 amRNSOakley agrees sale of Damovo to Eli Global
4th Jul 20183:49 pmRNSResult of AGM
28th Jun 20186:21 pmRNSDirector Dealing
28th Jun 20186:20 pmRNSDirector Dealing
26th Jun 201811:29 amRNSDirector Dealing
21st Jun 20187:00 amRNSNotice of Annual General Meeting
11th Jun 20187:00 amRNSPlesk acquisition of SolusVM
24th May 20187:00 amRNSOakley agrees sale of Facile to EQT
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20184:05 pmRNSHolding(s) in Company
26th Apr 20183:35 pmRNSDirector/PDMR Shareholding
26th Apr 20183:34 pmRNSDirector/PDMR Shareholding
13th Apr 20182:00 pmRNSDirector/PDMR Shareholding
20th Mar 201812:54 pmRNSDividend Announcement
15th Mar 20187:00 amRNSFinal Results
6th Mar 201811:57 amRNSHolding(s) in Company
22nd Feb 20187:00 amRNSSale of PARSHIP ELITE Group and Verivox
31st Jan 20187:00 amRNSTrading Update
18th Jan 20185:26 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSAcquisition of Career Partner Group
19th Sep 20177:00 amRNSDirector/PDMR Shareholding
15th Sep 20178:57 amRNSDirector/PDMR Shareholding
12th Sep 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.